Rulemaking Needed For Acetaminophen Skin-Reaction Label Warning – CHPA
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association encourages FDA to conduct a rulemaking to require label changes for acetaminophen OTCs the agency is suggesting in a draft guidance. The trade group also asks for clarity in the order warnings are placed on product labels.